Average Co-Inventor Count = 3.45
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Scifluor Life Sciences, Inc. (17 from 23 patents)
2. Kala Pharmaceuticals, Inc. (15 from 53 patents)
3. Merck + Co., Inc. (13 from 4,770 patents)
4. Ocuterra Therapeutics, Inc. (5 from 5 patents)
5. Amgen Inc. (1 from 1,974 patents)
6. Kata Pharmaceuticals, Inc. (1 from 1 patent)
52 patents:
1. 12497399 - Fluorinated integrin antagonists
2. 12286432 - Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
3. 11858900 - Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives
4. 11685737 - Fluorinated integrin antagonists
5. 11685738 - Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof
6. 11369611 - Therapeutic compounds and uses thereof
7. 10966987 - Therapeutic compounds and uses thereof
8. 10954244 - Compounds and uses thereof
9. 10758539 - Therapeutic compounds and uses thereof
10. 10676437 - Fluorinated 4-(substituted amino)phenyl carbamate derivatives
11. 10544151 - Compounds and uses thereof
12. 10398703 - Therapeutic compounds and uses thereof
13. 10351570 - Compounds and uses thereof
14. 10308647 - Fused imidazole derivatives as IDO/TDO inhibitors
15. 10301307 - Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof